title: Correlation between microRNA‑21 and sprouty homolog 2 gene expression in multiple myeloma.
abstract: The aim of the present study was to investigate the expression level of microRNA 21 (miR‑21) in the peripheral blood of patients with multiple myeloma (MM) and to investigate the correlation between miR‑21 and sprouty homolog 2 (SPRY2) gene expression levels in MM. A total of 30 patients with MM, 15 with monoclonal gammopathy of undetermined significance (MGUS) and 20 normal control (NC) outpatients were selected for the detection of miR‑21 and SPRY2 expression using reverse transcription-quantitative polymerase chain reaction. In addition, western blot analysis was performed to detect the expression of miR‑21 and SPRY2 in MM cell lines. The expression of miR‑21 in U‑266 cells following lipofectamine transfection of fluorescence‑labeled miR‑21 mimic/inhibitor was observed using a fluorescence microscope and the expression level of SPRY2 in the miR‑21 mimic/inhibitor‑transfected U‑266 cells was detected using western blot analysis. The miR‑21 expression level in the circulating serum of the MM patient group was significantly higher (P<0.01) than that of the MGUS and NC groups. The MM cell lines with high endogenous miR‑21 expression exhibited an expression level of SPRY2 that was significantly lower than that in the MM cells with low endogenous miR‑21 expression. The transfection efficiency of fluorescence‑labeled miR‑21 mimic/inhibitor was >90%. Compared with the miR‑21 expression level in untreated U‑266 cells (0.82±0.13), the expression level of miR‑21 was increased by 120.2‑fold in miR‑21 mimic‑transfected cells (98.6±14.2; P<0.001) and was decreased by 61.9% in the miR‑21 inhibitor‑transfected cells (0.37±0.06; P<0.05). The grayscale value of protein bands demonstrated that SPRY2 protein expression significantly decreased in miR‑21 mimic‑transfected U‑266 cells compared with that in the inhibitor‑transfected, siRNA‑transfected and untreated cells (P<0.01). miR‑21 may represent a negative regulator involved in the downregulation of SPRY2 in MM. miR‑21 is closely associated with the pathogenesis, progression and prognosis of MM and may thus be used as an indicator of poor MM prognosis.
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Jin-Hang
authors: JH
authors: Wang
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Wen-Wen
authors: WW
authors: Zheng
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Shi-Tong
authors: ST
authors: Cheng
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Bo-Xin
authors: BX
authors: Liu
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Fu-Rong
authors: FR
authors: Liu
authors: Laboratory Department of the First Affiliated Hospital of China Medical University, China Medical University School of Medicine Based in Shenyang, Teaching and Research Section of Cell Biology, Shenyang, Liaoning 110001, P.R. China.
authors: Jian-Qing
authors: JQ
authors: Song
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D005260:Female; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D035683:MicroRNAs / Q000097:blood / Q000235:genetics*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics* / Q000473:pathology; D009367:Neoplasm Staging; D014162:Transfection
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; C524940:MIRN21 microRNA, human; D008565:Membrane Proteins; D035683:MicroRNAs; C485561:SPRY2 protein, human
references: Nat Protoc. 2008;3(6):1101-8
references: 18546601
references: Oncogene. 2008 Apr 3;27(15):2128-36
references: 17968323
references: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12885-90
references: 18728182
references: Mol Pharmacol. 2009 Oct;76(4):679-91
references: 19570949
references: J Hepatol. 2010 Jul;53(1):98-107
references: 20447717
references: Leuk Lymphoma. 2010 Dec;51(12):2270-4
references: 21067440
references: Curr Med Chem. 2010;17(36):4427-32
references: 21062260
references: Mol Carcinog. 2011 Feb;50(2):136-42
references: 21229610
references: Cancer Biol Ther. 2011 Jan 1;11(1):111-21
references: 21099344
references: Blood. 2011 Jun 9;117(23):6063-73
references: 21447828
references: Leuk Lymphoma. 2011 Oct;52(10):1991-8
references: 21718132
references: Int J Mol Med. 2012 May;29(5):920-6
references: 22322462
references: J Proteome Res. 2012 Apr 6;11(4):2078-90
references: 22316494
references: Acta Pharmacol Sin. 2013 Jan;34(1):157-66
references: 23247593
references: Clin Cancer Res. 2013 Apr 15;19(8):2096-106
references: 23446999
references: J Clin Oncol. 2013 Jun 20;31(18):2347-57
references: 23690408
references: Br J Haematol. 2003 Jun;121(5):749-57
references: 12780789
references: Nucleic Acids Res. 2005;33(20):e179
references: 16314309
references: J Biol Chem. 2006 Oct 6;281(40):29993-30000
references: 16893902
references: Blood. 2007 Aug 15;110(4):1330-3
references: 17496199
references: J Biol Chem. 2008 Jan 25;283(4):2002-9
references: 18048363
references: Angiogenesis. 2008;11(1):53-62
references: 18219583
references: Mol Biol Cell. 2008 Aug;19(8):3272-82
references: 18508928